188 results about "Menstrual cycle" patented technology

Provided are methods and kits for administering progestogen as a glucocorticoid sensitizer to restore corticosteroid sensitivity or reverse the glucocorticoid insensitivity or enhance glucocorticoid sensitivity, in order to treat one or more glucocorticoid insensitivity related diseases or conditions. For example, these include methods for reversing the glucocorticoid insensitivity in a subject having no history of menstrual cycle-related exacerbation or allergy to self-hormones, particularly progesterone, such as premenstrual or perimenstrual deterioration in the symptoms, e.g., premenstrual worsening of atopic dermatitis or premenstrual exacerbations of asthma, and exhibiting relatively or totally refractory responses to glucocorticoid therapy, e.g., glucocorticoid resistance. The methods and kits provide for the administration of a sex hormone to the subject who is corticosteroid dependent or corticoid resistant or unresponsive or intolerant to corticosteroids.

The present invention relates to a hormonal contraceptive product having two hormonal components, an estrogen and a gestagen, and a method for the continuous suppression of the menstrual cycle by uninterrupted administration of the product of the invention.

A portable electronic device for reducing periodic cramping about an abdominal cavity of a user during a menstrual cycle includes an elastic panty garment, a controller removably attached directly to an outer surface of the panty garment and a plurality of electro-mechanical transducers generating output vibrations, and a plurality of heatable magnetic straps directly coupled to the outer surface of the panty garment. The heatable magnetic straps extend along anterior and posterior faces of the panty garment and are simultaneously actuated to a desired temperature level while the transducers are actuated to an on position. The heatable magnetic straps being freely movable along the outer surface of the panty garment while the transducers are nested within respective pouches.

The present invention relates to a hormonal contraceptive product having two hormonal components, an estrogen and a gestagen, and a method for the continuous suppression of the menstrual cycle by uninterrupted administration of the product of the invention.

A method for preventing or treating a catamenial migrainous disorder in a female subject comprises administering to a vulvovaginal surface of the subject a pharmaceutical composition that is bioadhesive thereto and comprises at least one estrogenic compound in an amount of about 50 μg to about 1000 μg estradiol equivalent per unit dose of the composition. A related method comprises administering to a vulvovaginal surface of the subject a pharmaceutical composition comprising at least one estrogenic compound, wherein upon administration of the composition to the vulvovaginal surface, a decline in serum estradiol concentration during a luteal phase of a menstrual cycle is moderated.

The invention provides a method for providing contraception in a woman, wherein the woman is administered with a progestogen-only contraception composition once-a-month between the 1st and the 10th day of the woman menstrual cycle. It is further provided a system for reminding a woman of taking such contraceptive composition.

The present compounds are intermediates for the preparation of quinoline derivatives and compositions having gonadotropin-releasing hormone antagonistic activity useful as propylactics or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, uterine or cervical cancer, breast cancer, pituitary adenoma), benign prostatic hypertrophy, myoma of the uterus, endometriosis, precocious puberty, amenorrhea, premenstrual syndrome, polycystic ovary syndrome and acne vulgaris; are effective as a fertility controlling agent in both sexes (e.g. a pregnancy controlling agent and a menstrual cycle controlling agent); can be used as a male or female contraceptive, as an ovulation-inducing agent; can be used as an infertility treating agent by using a rebound effect owing to a stoppage of administration thereof; and are useful for modulating estrous cycles in animals in the field of animal husbandry, as agents for improving the quality of edible meat or promoting the growth of animals, and as agents for promoting spawning in fish.

A menstrual cycle monitoring apparatus 100 that determines a menstrual cycle of a user is composed of: a clock unit 103 that measures a usage quantity (i.e., a cleansing time period taken from when a bidet switch 111 is pressed to when a stop switch 113 is pressed) of the bidet apparatus 116 that cleanses the vaginal area; a memory unit 104 that accumulates a history of the measured usage quantity for each date; and a menstrual cycle determining unit 105 that determines the menstrual cycle of the user on the basis of the history of the usage quantity accumulated in the memory unit 104.

A single axis rotatable disc calendar for calculating time periods and future dates based on current or past events is disclosed. In particular, calculators for determining fertility timing, testing and treatment dates have a base circular calendar (61) and one or more discs (58, 59, 60) containing information about menstrual cycles and ovulation events. The base circular calendar has 365 divisions (67) for the days in the year or 153 divisions for a shortened calendar excluding February. A separate February calendar with a leap February month is provided on the back of the base.

Devices and systems for facilitating the flow of menses through the cervix and for shortening the duration of menstruation include a pressure oscillations generating unit insertable into a vagina and configured for delivering pressure oscillations and / or acoustic waves and / or shock waves to the vagina and cervix to change the flow properties of menses fluid. The pressure oscillations generating unit may include one or more vibratable or movable members for generating pressure oscillations which may be powered by an internal or external power source. The devices may optionally include an absorbing member or a menses collecting member. A method of menstruation duration shortening includes placing the device within the vagina and applying pressure oscillations to the vagina or to a vaginal chamber formed within the vagina for increasing the flow rate of menses and shortening menstruation duration.

An electronic device for recording a woman's menstrual cycle, recalling each recorded cycle and updating each cycle with respect to normal and abnormal menstrual flow; a frequency button is provided to record the average number of days between periods; a projection button is provided to project future period dates and is used in combination with an override button which recalls the number of days between periods and is usable to customize future period projection dates to an individual user's natural health response by setting and entering a new override value; an exam button is included to set and store breast and Papanicolaou, cervicovaginal or PAP smear exam dates and a reminder message is displayed for five seconds when the device is turned on once the stored exam dates are within two months of termination.

The present invention provides a method for determining the gender of an unborn child by assaying the overall reducing / oxidizing or redox activity of the maternal urine or other body fluid. The method can be used to determine fetal gender at any time point during the entire pregnancy, the earliest being the first day of a missed menstruation. The body fluid may be processed before assaying. Processing may involve aging the body fluid, or purification of various fractions. The methods of the present invention also provide for a means for pre-conception baby gender planning by assaying the overall redox activity of a non-pregnant female's urine or other body fluid. The overall redox activity of a urine sample correlates with the gender specific compatibility of the ovum being released during a particular menstrual cycle. Therefore, assaying the overall redox activity of a non-pregnant female's urine will help a couple conceive a baby having a desired gender.

A gonadotropin-releasing hormone antagonistic composition, which comprises an optionally substituted condensed-bicyclic compound consisting of a homo or hetero 5 to 7 membered ring and a homo or hetero 5 to 7 membered ring is effective as a propylactic or therapeutic agent for the prevention or treatment of several hormone dependent diseases, for example, a sex hormone dependent cancer (e.g. prostatic cancer, cancer of uterine cervix, breast cancer, pituitary adenoma), benign prostatic hypertrophy, myoma of the uterus, endometriosis, precocious puberty, amenorrhea, premenstrual syndrome, polycystic ovary syndrome and acne vulgaris; is effective as a fertility controlling agent in both sexes (e.g. a pregnancy controlling agent and a menstrual cycle controlling agent); can be used as a contraceptive of male or female, as an ovulation-inducing agent of female; can be used as an infertility treating agent by using a rebound effect owing to a stoppage of administration thereof; is useful as modulating estrous cycles in animals in the field of animal husbandry, as an agent fro improving the quality of edible meat or promoting the growth of animals; is useful as an agent of spawning promotion in fish.

The invention discloses a novel Chinese medicinal composition for treating delayed menstrual cycle and a preparation method thereof. The Chinese medicinal composition mainly comprises the following raw material medicaments: root of red-rooted salvia, szechuan lovage rhizome, safflower, peach seed, roasted pangolin scales, motherwort herb, medlar, tuber fleeceflower root, white paeony root, pilose asiabell root, raw astragalus, cinnamomvine, Chinese angelica, roasted frankincense, roasted myrrh, cassia bark, cassia twig, dried ginger, medcinal evodia fruit, tangerine peel, green tangerine peel, immature bitter orange, cyperusrotundus, szechwan chinaberry fruit, rhizoma corydalis, radix curcumae, suberect spatholobus stem, cowherb seed, radix rehmanniae preparata, donkey-hide glue and the like. The Chinese medicinal composition can be prepared into any one common orally-taken preparation by a conventional Chinese medicinal preparation method. The Chinese medicinal composition can remarkably improve the symptoms: delayed menstrual cycle, delayed menstruation, delayed menstrual cycle, scant menstrual flow, lumpy menses with dark color, lesser abdomen, distention and pain of the breast, depression, lusterless complexion, fatigue and lack of strength and other symptoms, and has the advantages of extract clinical treatment effect, remarkable treatment effect, quick response, basically no toxic or side effect and the like.

The invention discloses a women's ovulation detecting system and method. The women's ovulation detecting system comprises an input module, a menstrual period management module and an ovulation detecting module, a client side inputs the date, time and period of current menstruation into the ovulation detecting system through the input module, the menstrual period management module is connected with the input module and stores and manages data of the date, the time and the period of current menstruation, and the ovulation detecting module is connected with the menstrual period management module and detects the ovulation result according to the ovulation sample comparison result and the data of the menstrual period management module.

Provided are methods and kits for administering progestogen as a glucocorticoid sensitizer to restore corticosteroid sensitivity or reverse the glucocorticoid insensitivity or enhance glucocorticoid sensitivity, in order to treat one or more glucocorticoid insensitivity related diseases or conditions. For example, these include methods for reversing the glucocorticoid insensitivity in a subject having no history of menstrual cycle-related exacerbation or allergy to self-hormones, particularly progesterone, such as premenstrual or perimenstrual deterioration in the symptoms, e.g., premenstrual worsening of atopic dermatitis or premenstrual exacerbations of asthma, and exhibiting relatively or totally refractory responses to glucocorticoid therapy, e.g., glucocorticoid resistance. The methods and kits provide for the administration of a sex hormone to the subject who is corticosteroid dependent or corticoid resistant or unresponsive or intolerant to corticosteroids.

A disposable menstrual panty comprising of a garment having a front portion, a rear portion, a crotch portion having two leg openings, a right leg opening and a left leg opening and a waist portion as to be worn about the lower torso of a women before during and after menstrual cycle. A sanitary napkin is stitched and permanently bonded with an adhesive material within the entire crotch portion that will not slide or curl up around the edges ensuring stability. Garment also has side attachments that join together front portions and rear portion of panty at both left and right sides of panty using velcro attachments or alternate adhesive tape fasteners or tie string.

The invention discloses a Chinese medicinal composition for treating preceded menstrual cycle and a preparation method thereof. The Chinese medicinal composition mainly comprises the following raw material medicaments: charred sanguisorba, charred Chinese arborvitae twig, Japanese thistle herb or root, common cephalanoplos herb, lalang grass rhizome, radix pseudo-ginseng, India madder root, cattail pollen, rosewood heart wood, carbonized human hair, hairyvein agrimonia herb and bud, plant soot, petiolus trachyc, root of red-rooted salvia, safflower, peach seed, hiraute shiny bugleweed herb, motherwort herb, suberect spatholobus stem, cowherb seed, Chinese rose flower, ground beeltle, dragon's blood, sappan wood, pilose asiabell root, Chinese angelica, white paeony root, raw astragalus, flastem milkvetch seed, eucommia bark, tuber fleeceflower root, radix rehmanniae preparata, medlar, cuttlebone and the like. The Chinese medicinal composition can be prepared into any one common orally-taken preparation by a conventional Chinese medicinal preparation method. The Chinese medicinal composition can remarkably improve the symptoms: preceded menstrual cycle, advanced menstrual cycle, intermenstrual bleeding, menorrhagia, incessant menses and the like, and has the advantages of extract clinical treatment effect, remarkable treatment effect and quick response. The Chinese medicinal composition also has the advantages of low cost, basically no toxic or side effect and the like.

A method and apparatus for personal screening for early signs of cervical cancer is claimed, whereby the user performs daily or almost daily a diagnostic self-check for some other aspect of reproductive health, and the electronic testing for cervical cancer type of tissue aberration is performed automatically in the background. The screening is invisible to the user, causing no anxiety and no discomfort. The user only becomes alerted to the need to see a physician if a preset condition of reproducibility is reached in the background evaluation of the measurement data if the aberrant pattern has been detected consecutively in a preset number of menstrual cycles, the device prompts the woman to see a physician with a view to undergoing a more demanding definitive diagnostic examination such as colposcopy with biopsy. The invention provides the diagnostic screen in a manner that does not cause the discomfort, anguish and anxiety associated with the Pap smear screen of the prior art.

An electronic system for determining a time of the temperature nadir of a female human during the menstrual cycle comprises a wearable device (1) that includes a first sensor system (104), configured to determine a temperature of the female human, and a second sensor system (101, 102, 103), configured to determine one or more further physiological parameters of the female human. The electronic system further comprises a processor (13, 30, 40), configured to determine a detected starting point of the fertility phase of the female human, using the one or more further physiological parameters of the female human. The processor (13, 30, 40) is further configured to detect the temperature nadir as a temporary decrease in the temperature, using the detected starting point of the fertility phase of the female human. The time of the temperature nadir is used as an indicator of the time of ovulation and peak oestrogen level.

A system for customized prediction of a menstruation period or a fertility period is provided. The system includes a vital information measurer for measuring vital information about a user, a basic menstruation information generator for calculating the first day of menstruation or an ovulation day using the vital information received from the vital information measurer and outputting the first day of menstruation or the ovulation day as basic menstruation information, a menstruation cycle modeler having a menstruation cycle model representing a menstruation cycle as a function with a predetermined period, and a model parameter estimator for estimating and compensating a menstruation cycle parameter of the menstruation cycle model using the basic menstruation information received from the basic menstruation information generator.

The invention discloses a traditional Chinese medicine combination menstruation-regulating soup for treating a polycystic ovary syndrome, which comprises a menstruation-regulating soup No.1 and a menstruation-regulating soup No.2, wherein the menstruation-regulating soup No.1 is prepared by decocting traditional Chinese medicines of angelica, astragalus root, notopterygium root, prepared rehmannia root, nutgrass galingale rhizome, red paeonia, radix salviae miltiorrhizae, herba lycopi, bupleurum, safflower and motherwort; and the menstruation-regulating soup No.2 is prepared by decocting the traditional Chinese medicines of angelica, astragalus root, notopterygium root, prepared rehmannia root, Chinese yam, wolfberry fruit, radix dipsaci, dodder, glossy privet fruit and eclipta alba. The clinical research data shows that the ovulation induction with Western medicines and menstruation regulation with the traditional Chinese medicine menstruation-regulating soup according to menstrual cycles can be simultaneously applied to treat both symptoms and root causes and achieve the advantages of short treatment course, no obvious side effect and low price, thereby being a treatment method worth generalizing and having favorable clinical application values.

In this invention, there is woven into or laminated to the fabric, (all types of fabrics or nonwoven material) a laminate or substance which is leak proof, and breathable. This invention is designed with feminine care in mind, especially during the female menstrual cycle. It can also be used at any time by a person female or male who feel the need to wear a protective leak proof, breathable garment. All females have various menstrual cycles and flow at various rates and during the heavier flowing days, it is very stressful worrying if you are going to leak through the feminine menstrual product to your outer clothing. Females have to dress accordingly, i.e., wearing dark clothing, long shirts, or long sweaters, etc., in the event of seepage through to their outer garments, to help minimize the embarrassing situation. During sleeping it is almost impossible to prevent leakage onto garments and bedding. By wearing this ultimate wear called Finally (a leak proof breathable under garment or swim wear), it will prevent leakage, and it is breathable thereby allowing continued comfort.

A method and system for tracking a menstrual cycle of at least one female person using a suitable microprocessor based device. The method includes: recording and saving data associated with the menstrual cycle; recording and saving information on flow associated with the menstrual cycle; recording and saving information on moods associated with the person; and, recording and saving notes associated with the person or menstrual cycle. The menstrual cycle is automatically monitored and projections are made based upon at least a portion of the recorded and stored data associated the menstrual cycle.

The invention discloses a medicine for treating the irregular menstrual period and a preparation method thereof. The medicine is prepared from angelica sinensis, cinnamon, rhizoma cyperi, turmeric, red flower, hematoxylon, sunflower, codonopsis pilosula and moutan bark according to a certain weight proportion. The medicine has the effects of nourishing yin, clearing the heat, promoting qi to activate blood, dissipating blood stasis to stop pain, tonifying kidneys, stopping bleeding and adjusting the menstrual period, has a quick response of treating the irregular menstrual period and is short in treatment period.

Devices and systems for facilitating the flow of menses through the cervix and for shortening the duration of menstruation include a pressure oscillations generating unit insertable into a vagina and configured for delivering pressure oscillations and / or acoustic waves and / or shock waves to the vagina and cervix to change the flow properties of menses fluid. The pressure oscillations generating unit may include one or more vibratable or movable members for generating pressure oscillations which may be powered by an internal or external power source. The devices may optionally include an absorbing member or a menses collecting member. A method of menstruation duration shortening includes placing the device within the vagina and applying pressure oscillations to the vagina or to a vaginal chamber formed within the vagina for increasing the flow rate of menses and shortening menstruation duration.

The invention discloses a method, a device and a terminal for predicting menstrual cycles of women, and belongs to the field of technologies for applying computers. The method includes recognizing feature types of individual historical features related to the menstrual cycles of the target women; acquiring feature types corresponding to the individual historical features; selecting sample feature models from preset sample feature model libraries; carrying out iterative computation on the individual historical features in the sample feature models to obtain predicted durations of the menstrual cycles. The sample feature models are identical to the feature types. The predicted durations of the menstrual cycles correspond to the individual historical features. The method, the device and the terminal for predicting the menstrual cycles of the women have the advantage that the prediction accuracy of the menstrual cycles of the women can be improved by the aid of the method, the device and the terminal.

A method of birth control and hormone regulation comprises utilizing a vaginal ring worn continuously during each menstrual cycle. A vaginal ring delivers predetermined doses of progesterone and beta-estradiol. Beta-estradiol does not cause an increase in sex hormone binding globulin and thereby does not decrease a woman's levels of free testosterone and libido.

The invention relates to antisense oligonucleotides, in particular to antisense oligonucleotides to receptor genes, and the use of such oligonucleotides to regulate reproductive function and as chemopreventive or as a chemotherapeutic for various cancers, especially ovarian cancers. The invention also provides a method for preventing estrogen synthesis, a function of developing ovarian follicles, a therapeutic consideration for the prevention and treatment of some cancers of the breast, endometrium, ovary and cervix and of some endometriosis. The invention also relates to pharmaceutical compositions containing antisense oligonucleotides (ODNs, having 8 to 60 nucleotides) that act by binding to intracellular molecular targets. Optionally, for efficient delivery to a target DNA, RNA or protein, the ODNs may be covalently linked to a carrier moiety, which facilitates delivery of the ODN to the cytosol.